Main Article Content


Type 2 diabetes mellitus (T2DM) is associated with a high risk of early mortality and hypertension. The prevalence of AH is higher in patients with diabetes than in patients without diabetes. The higher prevalence of hypertension among diabetic patients is due to hyperglycaemia, insulin resistance and dyslipidaemia. All these factors cause the development and progression of atherosclerosis by destroying the blood vessel wall, contributing to vascular inflammation and endothelial cell dysfunction, disturbance of various cell types, such as platelets, and promoting coagulation. Thus, age, place of residence, duration of DM2, BMI, cigarette smoking and glycaemic control are significantly associated with hypertension. Studies using a larger sample size are needed to investigate the causes of uncontrolled blood pressure among diabetic patients and to develop appropriate measures for the prevention of cardiovascular complications[2,4,12].


Diabetes mellitus arterial hypertension hypertension peripheral

Article Details

How to Cite
Ellamonov, S. N., & Nasyrova, Z. A. (2021). Features of the Course of Hypertension among Patients with Type 2 Diabetes Mellitus. Central Asian Journal of Medical and Natural Science, 2(4), 11-16.


  1. 1. Eren NK, Harman E, Dolek D, Levent F. Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Arch Turk Soc Cardiol. 2014;42(8):733–740. doi:10.5543/tkda.2014.53384
  2. 2. Emdin CA, KazemRahimi B, Neal TC, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes a systematic review and meta-analysis. JAMA. 2015;313(6):603–615. doi:10.1001/jama.2014.18574
  3. 3. Chen G, Mcalister FA, Walker RL, Hemmelgarn BR, Campbell NRC, Commentary SE. Population science/epidemiology cardiovascular outcomes in Framingham participants the importance of blood pressure. Hypertension. 2011;57(5):891–897. doi:10.1161/HYPERTENSIONAHA.110.162446
  4. 4. Kamalova, Malika I., et al. "Pathomorphological Changes in Cerebral Vasculature in Ischaemic Stroke." JournalNX, vol. 7, no. 03, 2021, pp. 60-66.
  5. 5. Vargas-uricoechea H, Cáceres-acosta MF. Control of blood pressure and cardiovascular outcomes in type 2 diabetes. Open Med. 2018;13:304–323. doi:10.1515/med-2018-0048
  6. 6. International Diabetes Federation. Eighth Edition 2017. //doi:10.1016/S0140-6736(16)31679-8
  7. 7. Ward JD, Manes C, Ionescu-tirgoviste C, Witte DR, Fuller JH. Vascular risk factors and diabetic neuropathy. New Engl J Med Orig. 2005;352(4):341–350. doi:10.1056/NEJMoa032782
  8. 8. Shomurodov K.E.,Сomparative assessment of the influence of different methods of palatoplasty on the growth and development of the upper jaw in children with congenital cleft palate. European Science Review. – Vienna. Prague. – 2018. - №5-6. – Р.7-11
  9. 9. Forlemu AAMGASK, Menanga A, Ashuntantang G, Kingue S. Urinary protein excretion is associated with left ventricular hypertrophy in treatment- naïve hypertensive patients in an African hospital setting. Cardiorenal Med. 2013;3(3):57–62. doi:10.1159/000349938
  10. 10. Rodrigues JCL, Amadu AM, Dastidar AG, et al. ECG strain pattern in hypertension is associated with myocardial cellular expansion and diffuse interstitial fibrosis: a multi-parametric cardiac magnetic resonance study. Eur Hear J Cardiovasc Imaging. 2017;2017(18):441–450. doi:10.1093/ehjci/jew117
  11. 11. Siddiqui MA, Mittal PK, Brent P, et al. Secondary hypertension and complications: diagnosis and role of imaging. RadioGraphics. 2019;39(4):1036–1055. doi:10.1148/rg.2019180184
  12. 12. Esh H, Agabiti E, France MA, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Hear J. 2018;2018(00):1–98. doi:10.1097/HJH
  13. 13. Nithish C, Prasad RB, Reddy MRRM. Estimation of risk factors for cardio vascular diseases in urban & semi-urban population: a prospective observational study. International J Med Heal Res. 2019;2019(5):84–86.
  14. 14. Cochran WG. Sampling techniques, 2nd edn. JBiometrische Zeitschrift. 1965;7(3):203.
  15. 15. Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010;6(1):883–903. doi:10.2147/VHRM.S11681
  16. 16. Thiruvoipati T. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961. doi:10.4239/wjd.v6.i7.961
  17. 17. Zhou M, Wang A, Yu H. Link between insulin resistance and hypertension: what is the evidence from evolutionary biology? Diabetol Metab Syndr. 2014;6(12):1–8. doi:10.1186/1758-5996-6-12
  18. 18. Grillo A, Salvi L, Coruzzi P, Paolo Salv GP. Sodium intake and hypertension. Nutrients. 2019;11(1970):1–16. doi:10.3390/nu11091970
  19. 19. Unadike BC, Eregie A, Ohwovoriole AE. Prevalence of hypertension amongst persons with diabetes mellitus in Benin City, Nigeria. Niger J Clin Pract. 2011;14(3):300–302. doi:10.4103/1119-3077.86772
  20. 20. Mansour AA. Prevalence and control of hypertension in Iraqi diabetic patients: a prospective cohort study. Open Cardiovasc Med J. 2012;6(1):68–71. doi:10.2174/1874192401206010068
  21. 21. Williams B, Esh GM, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertension. 2018; 36 (10):1953–2041. doi:10.1093/eurheartj/ehy339
  22. 22. Benetos A, Davis AM, Michos ED, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(9):1273–1284. doi:10.2337/dci17-0026
  23. 23. Owolabi EO, Ter GD, Adeniyi OV, Seekoe E. Social epidemiology of hypertension in Buffalo City Metropolitan Municipality (BCMM): cross-sectional study of determinants of prevalence, awareness, treatment and control among South African adults. BMJ Open. 2017;7(6):1–12. doi:10.1136/bmjopen-2016-014349
  24. 24. Kabakov E, Koffle M, Karen Tordjman CN. Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors. J Cardiometabolic Syndr. 2006;1(2):95–101. doi:10.1111/j.1559-4564.2006.05513.
  25. 25. Tadesse K, Amare H, Hailemariam T, Gebremariam T. Prevalence of hypertension among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen Mohamed Memorial Hospital. J Diabetes Metab. 2018;9(1):4. doi:10.4172/2155-6156.1000792
  26. 26. Dedefo A, Galgalo A, Jarso G, Mohammed A. Prevalence of hypertension and its management pattern among type 2 diabetic patients attending, Adama Hospital Medical College, Adama. J Diabetes Metab. 2018;9(10):1–8. doi:10.4172/2155-6156.1000808
  27. 27. Mengesha AY. Hypertension and related risk factors in type 2 diabetes mellitus (DM) patients in Gaborone City Council (GCC) clinics, Gaborone. Afr Health Sci
  28. 28. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes d 2019.